Trondheim, Norway

Havard Sletta

USPTO Granted Patents = 4 


 

Average Co-Inventor Count = 7.1

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2009-2019

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: **Innovator Havard Sletta: Pioneering Antimicrobial Solutions**

Introduction

Havard Sletta, a distinguished inventor based in Trondheim, Norway, has made significant contributions to the realm of biotechnology with his innovative work. He holds four patents that showcase his commitment to advancing scientific knowledge, particularly in antimicrobial compounds and gene manipulation.

Latest Patents

One of his most recent inventions focuses on an **antimicrobial compound**, which provides a novel method for production and application as an effective antimicrobial agent. This compound's pharmaceutical compositions also highlight the use of actinomycetes bacteria in its production, showcasing a unique approach to addressing microbial challenges.

Another noteworthy patent involves the **NRPS-PKS gene cluster and its manipulation and utility**. This patent includes a nucleic acid molecule comprising a specific nucleotide sequence that plays a critical role in the synthesis of polyketide-based or macrolactam molecules. The potential for this innovation in the genetic and pharmaceutical fields is tremendous, offering new avenues for research and application.

Career Highlights

Havard Sletta has built a strong professional foundation through his work at renown institutions like SINTEF TTO AS and FMC Biopolymer AS. His experience in these organizations has not only honed his technical skills but has also led to groundbreaking inventions that positively impact society and health.

Collaborations

Sletta's innovative journey has been complemented by collaborations with esteemed colleagues, including Trond Erling Ellingsen and Geir Klinkenberg. Their combined expertise has fostered an environment of creativity and shared knowledge, driving forward important research initiatives.

Conclusion

Havard Sletta's contributions as an inventor have significantly advanced the field of biotechnology, particularly in the development of antimicrobial compounds and genetic research. His ongoing work continues to inspire innovation and has the potential to lead to further breakthroughs in health and science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…